The von Willebrand factor (vWF) is part of the primary hemostasis and promotes the
adhesion of circulating platelets to the activated or damaged endothelium. Increased
levels of plasma vWF have been found in patients suffering from severe infections
or malignant tumors suggesting that vWF contributes to diseases beyond coagulation
disorders. Under quiescent conditions, vWF is stored within endothelial cells in large
vesicles, the Weibel-Palade bodies. Upon stimulation, endothelial cells release the
densely packed vWF to the blood. The shear force of the blood flow enables the mechanical
elongation and thus exposure of the platelet binding domain A1. The required force
that mediates the dynamic change from a globular conformation to an elongated fiber
depends strongly on the anchorage of vWF to the endothelial cell surface. Previous
studies suggested that P-selectin and αvβ3 integrins may bind vWF to the vessel wall,
however their precise role is unclear and further binding partners have been proposed.
In the present study we investigated whether the endothelial glycocalyx is able to
anchor VWF fibers to the endothelium. The endothelial glycocalyx is composed of several
carbohydrates while heparan sulfate (HS) is one of the major components. We used microfluidic
devices to mimic the pathophysiological environment of malignant melanoma and we followed
the binding of vWF fibers and platelets to the endothelial cell surface by fluorescence
microscopy. Enzymatic removal of the HS or silencing of the exostosin glycosyltransferase
1, which contributes to the synthesis of HS, reduced the capability of endothelial
cells to anchor vWF fibers and to trap platelets. Stabilization of the glycocalyx
by chitosan oligosaccharides or overexpression of the HS decorated proteoglycan syndecan-1
(SDC-1) increased the retention of vWF at the cellular interface. The direct molecular
interaction between red fluorescent protein tagged SDC-1 and green fluorescent vWF
was further documented by live cell fluorescence microscopy and quantitative flow
cytometry. In a murine melanoma model, we found that protection of the endothelial
glycocalyx through the silencing of the HS degrading heparanase increased the number
of vWF fibers anchored to the wall of tumor blood vessels. In conclusion, we identified
HS chains exposed by proteoglycans such as SDC-1 as a relevant binding factor for
vWF at the endothelial cell surface in vitro and in vivo.